Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment
Background: The use of remdesivir in patients with coronavirus disease 2019 (COVID-19) and severe renal impairment has been approved; however, limited clinical data exist. Accordingly, we aimed to compare outcomes and adverse events associated with remdesivir in hospitalized patients with COVID-19,...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-07-01
|
| Col·lecció: | Journal of Infection and Public Health |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1876034124001874 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|